002370 Zhejiang Yatai Pharmaceutical
- 2.87
- -0.13-4.33%
Zhejiang Yatai Pharmaceutical News
Asia Pacific Pharmaceutical: Announcement on Passing the New Certification as a High-tech Enterprise
Asia Pacific Pharmaceutical: Second indicative announcement on the resale of Asia Pharmaceutical\'s conversion bonds
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares for the fourth quarter of 2024
Asia Pacific Pharmaceutical: First indicative announcement on Asia Pharmaceutical\'s resale of bonds
Asia Pacific Pharmaceutical: Announcement on the suspension of share conversion during the resale of Asia Pharma Bonds
Asia Pacific Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the resale of convertible corporate bonds of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Asia Pacific Pharmaceutical: China Investment Securities Co., Ltd.\'s inspection opinions on matters relating to the resale of convertible corporate bonds of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Asia Pacific Pharmaceutical: Announcement of Resolutions of the First Meeting of Bondholders in 2024
Asia Pacific Pharmaceutical: Legal Opinion of Beijing Guofeng (Hangzhou) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Asia Pacific Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on Zhejiang Asia Pacific Pharmaceutical Co., Ltd.\'s first bondholders\' meeting in 2024
Asia Pacific Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Asia Pacific Pharmaceutical: Notice on the Company\'s Obtaining a Notice of Approval of the Drug Supplement Application
Asia Pacific Pharmaceutical: China Investment Securities Co., Ltd.\'s verification opinion on Zhejiang Asia Pacific Pharmaceutical Co., Ltd. terminating a fund-raising investment project with convertible bonds
Asia Pacific Pharmaceutical: Announcement on Resolutions of the 18th Meeting of the 7th Board of Supervisors
Asia Pacific Pharmaceutical: Announcement on the cumulative amount of debt-for-equity swaps of Asia Pharmaceuticals reaching 10% of the total amount of shares issued by the company before the share conversion
Asia Pacific Pharmaceutical: Announcement on the termination of the convertible bond fund-raising investment project
Asia Pacific Pharmaceutical: Notice on holding the first bondholders\' meeting in 2024
Asia Pacific Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Asia Pacific Pharmaceutical: Announcement on Resolutions of the 33rd Meeting of the 7th Board of Directors
Asia Pacific Pharmaceutical: Announcement on early return of funds raised for temporary supplementary working capital
No Data
